Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Wednesday, April 23, 2025

View Back issues

HIV drugs

SAN FRANCISCO — A federal court in California preliminarily approved a $10 million settlement between Bristol-Myers Squibb and end-payor plaintiffs, which claimed the company and other pharmaceutical companies engaged in anti-competitive practices that kept less expensive generic HIV drugs from being available to the class members.

Read the order here .

Categories / Briefs, Business, Consumers, Health

Subscribe to our free newsletters

Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.

Loading...